pathway,tf,percent,,,
PI3K-Akt signaling pathway,242,97.98,0,,
Focal adhesion,155,99.36,0,,
Pathways in cancer,361,94.26,0,,
Protein digestion and absorption,64,90.14,0,,
Ras signaling pathway,138,84.66,0,,
Human papillomavirus infection,222,98.23,0,,
ECM-receptor interaction,60,98.36,0,,
Chemokine signaling pathway,117,87.31,0,,
mmuK signaling pathway,182,85.45,0,,
Endocytosis,173,91.53,0,,
Vascular smooth muscle contraction,63,65.62,0,,
cAMP signaling pathway,123,84.25,0,,
Regulation of actin cytoskeleton,158,91.86,0,,
Tuberculosis,101,84.87,0,,
Rap1 signaling pathway,143,87.73,0,,
Human cytomegalovirus infection,132,78.11,0,,
Cell adhesion molecules (CAMs),78,83.87,0,,
Toxoplasmosis,69,78.41,0,,
Platelet activation,70,74.47,0,,
Relaxin signaling pathway,92,92.93,0,,
Cell adhesion molecules,83,80.58,0,,
Yersinia infection,93,86.92,0,,
Apelin signaling pathway,93,83.78,0,,
MAPK signaling pathway,162,89.01,0,,
Intestinal immune network for IgA production,24,70.59,0,,
Lysosome,56,73.68,0.0001,,
Phagosome,86,88.66,0.0001,,
Osteoclast differentiation,76,79.17,0.0002,,
Amoebiasis,50,68.49,0.0003,,
Leukocyte transendothelial migration,79,91.86,0.0003,,
Lipid and atherosclerosis,116,81.69,0.0003,,
Human T-cell leukemia virus 1 infection,155,84.24,0.0003,,
AGE-RAGE signaling pathway in diabetic complications,76,93.83,0.0003,,
Hematopoietic cell lineage,47,71.21,0.0004,,
Neurotrophin signaling pathway,76,83.52,0.0004,,
Efferocytosis,75,69.44,0.0004,,
TNF signaling pathway,66,81.48,0.0007,,
HTLV-I infection,171,85.07,0.0007,,
Th1 and Th2 cell differentiation,47,72.31,0.0007,,
Bile secretion,14,24.14,0.0008,,
T cell receptor signaling pathway,76,78.35,0.001,,
Cell cycle,115,86.47,0.0012,,
Nuclear pore complex,27,84.38,0.0013,,
Salmonella infection,171,94.48,0.0013,,
Th17 cell differentiation,63,75.9,0.0014,,
Hippo signaling pathway,84,77.78,0.0016,,
Renin secretion,16,34.04,0.0016,,
Sphingolipid signaling pathway,73,78.49,0.0018,,
Arrhythmogenic right ventricular cardiomyopathy (ARVC),34,57.63,0.0018,,
Calcium signaling pathway,114,68.67,0.0019,,
IL-17 signaling pathway,52,88.14,0.002,,
Arrhythmogenic right ventricular cardiomyopathy,35,57.38,0.0021,,
Tight junction,111,88.8,0.002,,
Cushing syndrome,74,66.67,0.0022,,
Sphingolipid metabolism,10,37.04,0.0022,,
Inflammatory bowel disease,39,92.86,0.0022,,
Chagas disease,65,83.33,0.0027,,
Chagas disease (American trypanosomiasis),66,83.54,0.0028,,
GnRH signaling pathway,56,82.35,0.0044,,
Leishmaniasis,50,87.72,0.0047,,
C-type lectin receptor signaling pathway,62,77.5,0.0048,,
Rheumatoid arthritis,47,83.93,0.0052,,
Inflammatory bowel disease (IBD),38,95,0.0061,,
Axon guidance,120,83.33,0.0061,,
Hedgehog signaling pathway,22,57.89,0.0067,,
Proteoglycans in cancer,133,88.08,0.0069,,
Legionellosis,33,78.57,0.0074,,
Bacterial invasion of epithelial cells,42,76.36,0.0074,,
Gastric acid secretion,24,39.34,0.0076,,
NF-kappa B signaling pathway,57,76,0.0085,,
"Parathyroid hormone synthesis, secretion and action",55,73.33,0.0097,,
Fc gamma R-mediated phagocytosis,69,90.79,0.0099,,
Other glycan degradation,4,50,0.0113,,
Dilated cardiomyopathy,57,74.03,0.0118,,
Melanogenesis,46,60.53,0.0117,,
B cell receptor signaling pathway,52,85.25,0.0125,,
Serotonergic synapse,21,27.63,0.0127,,
Adipocytokine signaling pathway,39,69.64,0.0138,,
Hypertrophic cardiomyopathy,56,77.78,0.0142,,
Prostate cancer,52,70.27,0.0145,,
cAMP signaling,7,50,0.015,,
cGMP-PKG signaling pathway,94,72.31,0.0165,,
Cortisol synthesis and secretion,24,48,0.0188,,
Gap junction,48,75,0.0188,,
"Pentose phosphate pathway, non-oxidative phase, fructose 6P => ribose 5P",4,80,0.0222,,
Small cell lung cancer,59,83.1,0.0239,,
Glutamatergic synapse,31,39.74,0.0242,,
Hypertrophic cardiomyopathy (HCM),52,76.47,0.0248,,
"Growth hormone synthesis, secretion and action",56,62.22,0.0248,,
Long-term depression,12,30,0.0248,,
Circadian entrainment,36,52.17,0.0258,,
Toll-like receptor signaling,11,91.67,0.0274,,
Dopaminergic synapse,58,58,0.0282,,
Pancreatic secretion,26,37.68,0.0303,,
Estrogen signaling pathway,74,81.32,0.0323,,
Alcoholism,35,43.75,0.032,,
Kaposi sarcoma-associated herpesvirus infection,106,78.52,0.0351,,
Oocyte meiosis,66,69.47,0.037,,
Aldosterone synthesis and secretion,42,56.76,0.0367,,
Thyroid hormone synthesis,36,65.45,0.039,,
Adherens junction,60,80,0.0398,,
Adrenergic signaling in cardiomyocytes,82,66.13,0.0407,,
Viral carcinogenesis,130,92.2,0.0422,,
Ubiquitin mediated proteolysis,72,76.6,0.0421,,
PD-L1 expression and PD-1 checkpoint pathway in cancer,55,72.37,0.049,,
Toll-like receptor signaling pathway,56,84.85,0.0496,,
Vasopressin-regulated water reabsorption,21,67.74,0.0568,,
Viral protein interaction with cytokine and cytokine receptor,38,77.55,0.0568,,
Renal cell carcinoma,42,85.71,0.0571,,
Inositol phosphate metabolism,38,74.51,0.0637,,
Pertussis,40,78.43,0.0646,,
Diabetic cardiomyopathy,129,88.97,0.0648,,
Pentose phosphate pathway (Pentose phosphate cycle),5,62.5,0.0797,,
Progesterone-mediated oocyte maturation,56,70,0.0859,,
Breast cancer,69,70.41,0.0853,,
Measles,80,86.02,0.0997,,
Protein processing in endoplasmic reticulum,63,63,0.1106,,
Amphetamine addiction,24,42.86,0.112,,
"Alanine, aspartate and glutamate metabolism",15,45.45,0.1111,,
Herpes simplex virus 1 infection,216,85.04,0.1143,,
Viral myocarditis,33,67.35,0.1149,,
Inflammatory mediator regulation of TRP channels,38,50.67,0.1204,,
Human immunodeficiency virus 1 infection,127,81.94,0.1204,,
Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate,6,40,0.1206,,
Phospholipase D signaling pathway,89,82.41,0.1252,,
Arachidonic acid metabolism,25,54.35,0.1304,,
Polycomb repressive complex,47,69.12,0.138,,
Cholinergic synapse,51,60,0.1384,,
Aminoacyl-tRNA biosynthesis,2,6.67,0.1375,,
Phenylalanine metabolism,2,12.5,0.1431,,
Glycosaminoglycan biosynthesis - keratan sulfate,2,20,0.1478,,
RIG-I-like receptor signaling pathway,32,86.49,0.1477,,
Mucin type O-glycan biosynthesis,13,76.47,0.1483,,
Glycosphingolipid biosynthesis - lacto and neolacto series,3,16.67,0.1489,,
Olfactory transduction,2,6.9,0.1499,,
ATP-dependent chromatin remodeling,2,2.78,0.1572,,
Colorectal cancer,52,81.25,0.1565,,
Endocrine resistance,62,84.93,0.156,,
Oxytocin signaling pathway,96,84.21,0.1578,,
Hepatitis C,85,78.7,0.1647,,
Systemic lupus erythematosus,26,72.22,0.1638,,
Hippo signaling pathway - multiple species,11,55,0.1629,,
Regulation of lipolysis in adipocytes,21,51.22,0.1678,,
Salivary secretion,29,50.88,0.1685,,
Mineral absorption,5,16.13,0.1675,,
Apoptosis,80,83.33,0.1699,,
Malaria,23,74.19,0.1723,,
AMPK signaling pathway,56,61.54,0.1718,,
"Aminoacyl-tRNA biosynthesis, eukaryotes",2,7.69,0.1737,,
Morphine addiction,27,45,0.1741,,
"Spliceosome, Prp19/CDC5L complex",4,40,0.1734,,
Natural killer cell mediated cytotoxicity,60,82.19,0.1812,,
Nucleocytoplasmic transport,78,87.64,0.1838,,
Hepatitis B,105,84.68,0.1907,,
Chronic myeloid leukemia,44,75.86,0.1921,,
N-Glycan biosynthesis,15,50,0.191,,
Cellular senescence,92,73.6,0.1997,,
Cytokine-cytokine receptor interaction,149,90.85,0.2007,,
MCM complex,6,100,0.2076,,
Influenza A,85,80.19,0.2143,,
Herpes simplex infection,122,93.85,0.2134,,
Epstein-Barr virus infection,130,90.28,0.2219,,
Cholesterol metabolism,7,20,0.2212,,
JAK-STAT signaling pathway,76,76.77,0.2217,,
RNA transport,104,83.2,0.2335,,
Fc epsilon RI signaling pathway,41,82,0.2341,,
Autoimmune thyroid disease,17,68,0.2337,,
Jak-STAT signaling pathway,66,70.97,0.2325,,
Glycosphingolipid biosynthesis - globo and isoglobo series,8,100,0.2367,,
NOD-like receptor signaling pathway,110,91.67,0.2429,,
Various types of N-glycan biosynthesis,14,58.33,0.2446,,
TGF-beta signaling pathway,64,75.29,0.25,,
FoxO signaling pathway,73,73,0.2637,,
Motor proteins,117,96.69,0.27,,
Wnt signaling,10,43.48,0.2975,,
Cocaine addiction,20,54.05,0.3201,,
mTOR signaling pathway,67,67,0.3199,,
Pyrimidine metabolism,54,65.85,0.3316,,
DNA damage-induced cell cycle checkpoints,5,71.43,0.3371,,
Cardiac muscle contraction,29,43.28,0.3471,,
Signaling pathways regulating pluripotency of stem cells,71,70.3,0.3525,,
Hippo signaling pathway -multiple species,6,30,0.3632,,
Purine metabolism,76,62.3,0.3741,,
MicroRNAs in cancer,106,83.46,0.3841,,
Activin signaling,8,100,0.3906,,
Transcriptional misregulation in cancer,90,71.43,0.4062,,
Propanoate metabolism,9,34.62,0.4057,,
Chemical carcinogenesis - receptor activation,94,65.73,0.4102,,
ErbB signaling pathway,45,72.58,0.4142,,
Citrate cycle (TCA cycle),25,100,0.4136,,
Autophagy - animal,66,60.55,0.4164,,
Asthma,12,85.71,0.4337,,
Insulin resistance,51,60,0.4322,,
Neuroactive ligand-receptor interaction,67,40.12,0.431,,
Staphylococcus aureus infection,25,51.02,0.432,,
Antigen processing and presentation,38,79.17,0.4407,,
Thyroid hormone signaling pathway,61,65.59,0.4392,,
TGF-beta signaling,8,100,0.4494,,
Protein export,5,29.41,0.4611,,
BRCA1-associated genome surveillance complex (BASC),12,80,0.4595,,
beta-Alanine metabolism,28,100,0.4744,,
Apoptosis - multiple species,17,77.27,0.4882,,
Neutrophil extracellular trap formation,70,77.78,0.493,,
Primary immunodeficiency,20,74.07,0.5022,,
Longevity regulating pathway,46,62.16,0.5064,,
Gastric cancer,64,63.37,0.5233,,
"Spliceosome, 35S U5-snRNP",19,67.86,0.5247,,
Necroptosis,66,71.74,0.551,,
Cul4-DDB1-DDB2 complex,3,60,0.5539,,
Phosphatidylinositol signaling system,39,61.9,0.5602,,
Graft-versus-host disease,16,61.54,0.5715,,
Wnt signaling pathway,98,87.5,0.5779,,
Coronavirus disease - COVID-19,135,84.91,0.5822,,
Choline metabolism in cancer,57,78.08,0.5806,,
Cell cycle - G1/S transition,10,83.33,0.5839,,
Prion diseases,19,67.86,0.5995,,
GABAergic synapse,28,43.08,0.601,,
"O-glycan biosynthesis, mucin type core",11,84.62,0.6055,,
Longevity regulating pathway - multiple species,34,65.38,0.6374,,
Complement and coagulation cascades,32,49.23,0.653,,
Biosynthesis of cofactors,47,53.41,0.664,,
mRNA surveillance pathway,39,53.42,0.661,,
Fluid shear stress and atherosclerosis,91,85.85,0.6623,,
Alcoholic liver disease,67,69.79,0.6887,,
DNA replication,30,90.91,0.7031,,
Prolactin signaling pathway,29,55.77,0.7004,,
N-glycan precursor biosynthesis,7,87.5,0.7021,,
Lysine degradation,26,65,0.7033,,
Allograft rejection,17,65.38,0.703,,
Viral life cycle - HIV-1,29,72.5,0.756,,
Endometrial cancer,23,56.1,0.7724,,
Hippo signaling,3,25,0.7848,,
Cytosolic DNA-sensing pathway,37,88.1,0.7914,,
APC/C complex,11,91.67,0.7947,,
p53 signaling pathway,34,65.38,0.8094,,
Non-alcoholic fatty liver disease,100,84.75,0.8087,,
Mismatch repair,17,77.27,0.8107,,
Pentose phosphate pathway,6,24,0.8075,,
Other types of O-glycan biosynthesis,21,87.5,0.8278,,
Insulin secretion,35,50,0.83,,
Basal transcription factors,31,81.58,0.8365,,
Insulin signaling pathway,61,57.55,0.8394,,
HIF-1 signaling pathway,55,66.27,0.8371,,
Circadian rhythm,3,11.54,0.8553,,
Metabolic pathways,698,87.14,0.856,,
Melanoma,36,72,0.8598,,
One carbon pool by folate,5,35.71,0.8566,,
Pancreatic cancer,48,80,0.8626,,
Tryptophan metabolism,37,100,0.8613,,
Type I diabetes mellitus,18,56.25,0.8811,,
Folate biosynthesis,5,29.41,0.8888,,
Hedgehog signaling,3,37.5,0.8975,,
Proximal tubule bicarbonate reclamation,18,100,0.8992,,
Base excision repair,29,82.86,0.903,,
Endocrine and other factor-regulated calcium reabsorption,9,25.71,0.9176,,
Thermogenesis,107,70.86,0.9201,,
Sulfur metabolism,8,88.89,0.9206,,
Carbohydrate digestion and absorption,16,51.61,0.9269,,
ABC transporters,10,27.03,0.9312,,
Ovarian steroidogenesis,6,20.69,0.9291,,
RF-C complex,5,100,0.9268,,
EGFR tyrosine kinase inhibitor resistance,45,72.58,0.9287,,
Carbon metabolism,54,58.7,0.9282,,
RNA degradation,41,82,0.9258,,
Tyrosine metabolism,4,13.33,0.926,,
Basal cell carcinoma,21,56.76,0.9253,,
Spinocerebellar ataxia,63,66.32,0.9249,,
Biosynthesis of amino acids,33,53.23,0.9245,,
BER complex,5,62.5,0.9233,,
Glyoxylate and dicarboxylate metabolism,2,7.41,0.9334,,
Prion disease,157,87.71,0.9351,,
Nitrogen metabolism,5,41.67,0.9771,,
Holo-TFIIH complex,1,10,NA,,
Non-homologous end-joining,1,14.29,NA,,
